Scholar Rock Holding (SRRK) Cash from Financing Activities (2017 - 2026)
Scholar Rock Holding's quarterly Cash from Financing Activities came in at $193.8 million in Q1 2026, up 4548.26% year-on-year from $4.2 million in Q1 2025, and up 164.42% quarter-over-quarter from $73.3 million in Q4 2025.
Scholar Rock Holding has reported Cash from Financing Activities for 10 years, with the latest figure at $193.8 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 4548.26% year-over-year to $193.8 million; the trailing twelve-month figure through Mar 2026 stood at $418.0 million (up 19.2% YoY), and the FY2025 full-year result was $228.4 million, down 35.3% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $193.8 million, up from $73.3 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $346.4 million in Q4 2024, with the low at -$970000.0 in Q4 2022.
- Average Cash from Financing Activities over 5 years is $63.1 million, with a median of $4.7 million recorded in 2023.
- Year-over-year, Cash from Financing Activities plunged 123.66% in 2022 and jumped 86929.52% in 2025.
- Tracing SRRK's Cash from Financing Activities over 5 years: stood at -$970000.0 in 2022, then jumped by 10051.44% to $96.5 million in 2023, then surged by 258.82% to $346.4 million in 2024, then slumped by 78.84% to $73.3 million in 2025, then soared by 164.42% to $193.8 million in 2026.
- The last three Cash from Financing Activities figures came in at $193.8 million (Q1 2026), $73.3 million (Q4 2025), and $144.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 193.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193.79 Mn |
| Mar 31, 2026 | 193.79 Mn |
| Dec 31, 2025 | 73.29 Mn |
| Dec 31, 2025 | 73.29 Mn |
| Sep 30, 2025 | 144.47 Mn |
| Sep 30, 2025 | 144.47 Mn |
| Jun 30, 2025 | 6.47 Mn |
| Jun 30, 2025 | 6.47 Mn |
| Mar 31, 2025 | 4.17 Mn |
| Mar 31, 2025 | 4.17 Mn |
| Dec 31, 2024 | 346.37 Mn |
| Dec 31, 2024 | 346.37 Mn |
| Sep 30, 2024 | 166,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Jun 30, 2024 | -33,000.00 |
| Jun 30, 2024 | -33,000.00 |
| Mar 31, 2024 | 6.53 Mn |
| Mar 31, 2024 | 6.53 Mn |
| Dec 31, 2023 | 96.53 Mn |
| Dec 31, 2023 | 96.53 Mn |
| Sep 30, 2023 | 280,000.00 |
| Sep 30, 2023 | 280,000.00 |
| Jun 30, 2023 | 4.69 Mn |
| Jun 30, 2023 | 4.69 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | -970,000.00 |
| Dec 31, 2022 | -970,000.00 |
| Sep 30, 2022 | -451,000.00 |
| Sep 30, 2022 | -451,000.00 |
| Jun 30, 2022 | 195.77 Mn |
| Jun 30, 2022 | 195.77 Mn |
| Mar 31, 2022 | 481,000.00 |
| Mar 31, 2022 | 481,000.00 |
| Dec 31, 2021 | 39.70 Mn |
| Dec 31, 2021 | 39.70 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 607,000.00 |
| Jun 30, 2021 | 607,000.00 |
| Mar 31, 2021 | 2.74 Mn |
| Mar 31, 2021 | 2.74 Mn |
| Dec 31, 2020 | 246.46 Mn |
| Dec 31, 2020 | 246.46 Mn |
| Sep 30, 2020 | 368,000.00 |
| Sep 30, 2020 | 368,000.00 |
| Jun 30, 2020 | 595,000.00 |
| Jun 30, 2020 | 595,000.00 |
| Mar 31, 2020 | 399,000.00 |
| Mar 31, 2020 | 399,000.00 |
| Dec 31, 2019 | 818,000.00 |
| Dec 31, 2019 | 818,000.00 |
| Sep 30, 2019 | 6.12 Mn |
| Sep 30, 2019 | 6.12 Mn |
| Jun 30, 2019 | 42.10 Mn |
| Jun 30, 2019 | 42.10 Mn |
| Mar 31, 2019 | -157,000.00 |
| Mar 31, 2019 | -157,000.00 |
| Dec 31, 2018 | 16.93 Mn |
| Dec 31, 2018 | 16.93 Mn |
| Sep 30, 2018 | -1.46 Mn |
| Sep 30, 2018 | -1.46 Mn |
| Jun 30, 2018 | 78.97 Mn |
| Jun 30, 2018 | 78.97 Mn |
| Mar 31, 2018 | -167,000.00 |
| Mar 31, 2018 | -167,000.00 |
| Dec 31, 2017 | 46.72 Mn |
| Dec 31, 2017 | 46.72 Mn |
| Sep 30, 2017 | -167,000.00 |
| Sep 30, 2017 | -167,000.00 |